Mulpleta (lusutrombopag) NDC 59630-551

NDC codes

FDA NDC Directory

Product NDC (as listed)59630-551Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59630-0551Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
59630-551-07	59630055107	1 DOSE PACK in 1 CARTON (59630-551-07) / 7 TABLET, FILM COATED in 1 DOSE PACKMarketed from Aug 27, 2018
59630-551-77	59630055177	1 DOSE PACK in 1 CARTON (59630-551-77) / 7 TABLET, FILM COATED in 1 DOSE PACKMarketed from Aug 27, 2018 · Sample package

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Mulpleta
Generic name (nonproprietary): lusutrombopag
Active ingredients: Lusutrombopag — 3 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: SHIONOGI INC.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 210923
Marketing start: Aug 27, 2018
Listing expires: Dec 31, 2026
Identifiers: Product ID 59630-551_b520c88c-9064-4ffe-b33c-81fdfe795cadSPL ID b520c88c-9064-4ffe-b33c-81fdfe795cadSPL set ID f9fd0cfd-717d-4a87-99bc-de7b38807e55RxCUI 2054989, 2054995UNII 6LL5JFU42F

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459630055107 followed by a unit qualifier and the quantity

Package 59630-0551-07. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 29, 2020.

Indications (excerpt from the label)

MULPLETA is indicated for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure. MULPLETA is a thrombopoietin receptor agonist indicated for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)